Biogen News and Research

RSS
Christchurch Variant Offers Protection Against Early-Onset Alzheimer's

Christchurch Variant Offers Protection Against Early-Onset Alzheimer's

New Biomarker Offers Early Detection of ALS and FTD

New Biomarker Offers Early Detection of ALS and FTD

Predictive Models to Determine the Structure, Stability, Flexibility and Biology of RNA-Targeted Drugs

Predictive Models to Determine the Structure, Stability, Flexibility and Biology of RNA-Targeted Drugs

Memory T cells formed after prior infection or vaccination respond to omicron variant

Memory T cells formed after prior infection or vaccination respond to omicron variant

AF4-MALS: A powerful tool to separate viruses and aggregates

AF4-MALS: A powerful tool to separate viruses and aggregates

Alzheimer's: New Gene May Drive Earliest Brain Changes

Alzheimer's: New Gene May Drive Earliest Brain Changes

Experience Matters For Immune Cells

Experience Matters For Immune Cells

Improving drug targets for asthma and rheumatoid arthritis

Improving drug targets for asthma and rheumatoid arthritis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.